Literature DB >> 29550303

Trends in cigarette smoking among adults with HIV compared with the general adult population, United States - 2009-2014.

Emma L Frazier1, Madeline Y Sutton2, John T Brooks1, R Luke Shouse1, John Weiser1.   

Abstract

Smoking increases HIV-related and non-HIV-related morbidity and mortality for persons with HIV infection. We estimated changes in cigarette smoking among adults with HIV and adults in the general U.S. population from 2009 to 2014 to inform HIV smoking cessation programs. Among HIV-positive adults, rates of current smoking declined from 37.6% (confidence interval [CI]: 34.7-40.6) in 2009 to 33.6% (CI: 29.8-37.8) in 2014. Current smoking among U.S. adults declined from 20.6% (CI: 19.9-21.3) in 2009 to 16.8% (CI: 16.2-17.4) in 2014. HIV-positive adults in care were significantly more likely to be current smokers compared with the general U.S. population; they were also less likely to quit smoking. For both HIV-positive adults in care and the general population, disparities were noted by racial/ethnic, educational level, and poverty-level subgroups. For most years, non-Hispanic blacks, those with less than high school education, and those living below poverty level were more likely to be current smokers and less likely to quit smoking compared with non-Hispanic whites, those with greater than high school education, and those living above poverty level, respectively. To decrease smoking-related causes of illness and death and to decrease HIV-related disparities, smoking cessation interventions are vital as part of routine care with HIV-positive persons. Clinicians who care for HIV-positive persons who smoke should utilize opportunities to discuss and implement smoking cessation strategies during routine clinical visits. Published by Elsevier Inc.

Entities:  

Keywords:  Cessation; Cigarettes; General population; HIV; Smoking; Trend

Mesh:

Year:  2018        PMID: 29550303     DOI: 10.1016/j.ypmed.2018.03.007

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  40 in total

1.  Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research.

Authors:  Robert A Schnoll; Morgan Thompson; Katrina Serrano; Frank Leone; David Metzger; Ian Frank; Robert Gross; Karam Mounzer; Rachel F Tyndale; Jessica Weisbrot; Miles Meline; Ronald G Collman; Rebecca L Ashare
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

2.  Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic.

Authors:  D R Bailey Miles; Usama Bilal; Heidi E Hutton; Bryan Lau; Catherine R Lesko; Anthony Fojo; Mary E McCaul; Jeanne Keruly; Richard D Moore; Geetanjali Chander
Journal:  J Health Care Poor Underserved       Date:  2019

3.  Cross-validation of transtheoretical model smoking cessation measures in Chicago WIHS women smokers with and at risk for HIV.

Authors:  Colleen A Redding; David Goldberg; Kathleen M Weber; Hui-Qing Yin; Andrea L Paiva; Jane Burke-Miller; Mardge H Cohen; Joseph S Rossi
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

4.  Acceptability of electronic nicotine delivery systems (ENDS) among HIV positive smokers.

Authors:  Jessica Yingst; Jonathan Foulds; John Zurlo; Michael B Steinberg; Thomas Eissenberg; Ping Du
Journal:  AIDS Care       Date:  2019-11-07

5.  Pain self-efficacy, race, and motivation to quit smoking among persons living with HIV (PLWH).

Authors:  Lisa R LaRowe; Yvette Rother; Jessica M Powers; Michael J Zvolensky; Peter A Vanable; Joseph W Ditre
Journal:  Addict Behav       Date:  2020-01-23       Impact factor: 3.913

6.  Examining Mortality to Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center.

Authors:  Adam M Ressler; Mona Abdo; Samantha MaWhinney; Steven C Johnson; Kristine M Erlandson
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-23       Impact factor: 2.205

Review 7.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

8.  Persistent Disparities in Smoking Rates Among PLWH Compared to the General Population in Philadelphia, 2009-2014.

Authors:  Robert Gross; Kathleen A Brady; Cedric H Bien-Gund; Grace H Choi; Antonios Mashas; Pamela A Shaw; Melissa Miller
Journal:  AIDS Behav       Date:  2021-01

9.  National Estimates of Prevalence, Time-Trend, and Correlates of Smoking in US People Living with HIV (NHANES 1999-2016).

Authors:  Taghrid Asfar; Amanda Perez; Patrick Shipman; Adam W Carrico; David J Lee; Maria Luisa Alcaide; Deborah L Jones; Judson Brewer; Tulay Koru-Sengul
Journal:  Nicotine Tob Res       Date:  2021-08-04       Impact factor: 4.244

10.  A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study.

Authors:  E Jennifer Edelman; James Dziura; Yanhong Deng; Krysten W Bold; Sean M Murphy; Elizabeth Porter; Keith M Sigel; Jessica E Yager; David M Ledgerwood; Steven L Bernstein
Journal:  Contemp Clin Trials       Date:  2021-03-29       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.